Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b (Q28377253)

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

The inhibitory effect of rosmarinic acid on complement involves the C5 convertase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Complement-dependent stimulation of prostacyclin biosynthesis: inhibition by rosmarinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Influence of rosmarinic acid on opsonization and intracellular killing of Escherichia coli and Staphylococcus aureus by porcine and human polymorphonuclear leucocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Rosmarinic acid inhibits external oxidative effects of human polymorphonuclear granulocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Investigation of mechanism-based inhibitors of complement targeting the activated thioester of human C3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Tyrosine is a potential site for covalent attachment of activated complement component C3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

A fluorimetric assay for native C3. The hemolytically active form of the third component of human complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Binding reaction between the third human complement protein and small molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Covalent binding efficiency of the third and fourth complement proteins in relation to pH, nucleophilicity, and availability of hydroxyl groups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Complement-specific antibodies: Designing novel anti-inflammatories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Synthetic peptide inhibitors of complement serine proteases--I. Identification of functionally equivalent protease inhibitor sequences in serpins and inhibition of C1s and D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

The effect of FUT-175 (Nafamstat Mesilate) on C3a, C4a and C5a generation in vitro and inflammatory reactions in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab')2 fragments and rosmarinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

Inhibition of experimentally induced microvascular injury by rosmarinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900044-1

10.1016/S0006-2952(99)00044-1

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1738578

1738578

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference